StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

NervGen Pharma's enterprise value was $91.88M on Nov 11, 2026, against $288.67M a year earlier. Over the last 3 years it ranged from $76.69M to $381.27M, with a median of $136.60M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$91.88M-75.9%
2025Dec 31, 2025$381.27M+212.9%
2024Dec 31, 2024$121.85M–

More NervGen Pharma figures

See a number that looks wrong?